연구성과로 돌아가기

2024 연구자 정보 (35 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Alotaibi, Ahmed
(Alotaibi, A)
King Faisal Specialist Hosp & Res, Canc Ctr Excellence, Riyadh, Saudi Arabia

[JCR상위 1.5] The 66th ASH Annual Meeting Abstracts ORAL ABSTRACTS SCIE 1.5 HEMATOLOGY
Anithkumar, Monunith
(Anithkumar, M)
Jeju Natl Univ, Fac Appl Energy Syst, Nanomat & Syst Lab, Major Mechatron Engn, Jeju 63243, South Korea

[JCR상위 1.5] Augmented neuromuscular transmission: bridging physical and cognitive practices through intrinsic hybrid nanogenerator-integrated confirmation analysis system SCIE 1.5 MATERIALS SCIENCE, COMPOSITES;NANOSCIENCE & NANOTECHNOLOGY sathyaprabakaran.94@gmail.com;monunith.a@gmail.com;alluri@knu.ac.kr;kimsangj@jejunu.ac.kr;
Baek, Hee Jo
(Baek, HJ)
Chonnam Natl Univ, Hwasun Hosp, Dept Pediat, Hwasun, South Korea
Chonnam Natl Univ, Med Sch, Hwasun Hosp, Dept Pediat, Gwangju, South Korea


[JCR상위 1.5] Completion of the First Phase of Registration: Baseline Characteristics and Epidemiology of Hemophilia in Korea from the Korean Bleeding Disorder Registry (KBDR)
[JCR상위 33.2] The characteristics and treatment patterns in haemophilia B patients receiving recombinant coagulation factor IX
SCIE 1.5 HEMATOLOGY
Bang, Soo-Mee
(Bang, SM)
Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea

[JCR상위 1.5] Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon
[JCR상위 1.5] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
[JCR상위 1.5] Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea
SCIE 1.5 HEMATOLOGY
Bazarbachi, Ali
(Bazarbachi, A)
Amer Univ Beirut, Dept Med, Beirut, Lebanon

[JCR상위 1.5] Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? SCIE 1.5 HEMATOLOGY
Bbiavasco, Francesc
(Bbiavasco, F)
Univ Freiburg, Med Ctr, Dept Med 1, Freiburg, Germany

[JCR상위 1.5] Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse SCIE 1.5 HEMATOLOGY
Biavasco, Francesca
(Biavasco, F)
Univ Freiburg, Dept Med 1, Med Ctr, Freiburg, Germany

[JCR상위 1.5] The 66th ASH Annual Meeting Abstracts ORAL ABSTRACTS SCIE 1.5 HEMATOLOGY
Byun, Ja Min
(Byun, JM)
Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med,Div Hematol Oncol, Seoul, South Korea AAI-2125-2020
Byun, Ja

[JCR상위 1.5] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment
[JCR상위 10.7] Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
SCIE 1.5 HEMATOLOGY kshmoon@dau.ac.kr;kihyunkimk@gmail.com;
Cai, Yu
(Cai, Y)
Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Shanghai, Peoples R China
Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China


[JCR상위 1.5] Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse
[JCR상위 1.5] The 66th ASH Annual Meeting Abstracts ORAL ABSTRACTS
[JCR상위 1.5] Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?
SCIE 1.5 HEMATOLOGY
Chae, Sun Young
(Chae, SY)
Eulji Univ, Sch Med, Uijeongbu Eulji Med Ctr, Dept Nucl Med, Uijongbu, South Korea AGZ-1893-2022
choi, sun ryoung

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
Chang, S.
(Chang, S)
제1저자 Kyungpook Natl Univ Hosp, Daegu, South Korea

[JCR상위 1.5] Performance evaluation of the automated cell image analyzer DI-60 for leukocyte differential count SCIE 1.5 MEDICAL LABORATORY TECHNOLOGY
Cheong, June-won
(Cheong, JW)
Yonsei Univ, Severance Hosp, Coll Med, Seoul, South Korea
Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea


[JCR상위 1.5] Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon
[JCR상위 1.5] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
[JCR상위 1.5] Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea
SCIE 1.5 HEMATOLOGY
Cho, Goo-Yeong
(Cho, GY)
Seoul Natl Univ, Bundang Hosp, Coll Med, Div Cardiol, Seongnam, South Korea

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
Choi, Chul Won
(Choi, CW)
Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea
Korea Univ, Coll Med, Coll Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul 138736, South Korea


[JCR상위 1.5] Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon
[JCR상위 1.5] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
[JCR상위 1.5] Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea
SCIE 1.5 HEMATOLOGY
Choi, Eui-Young
(Choi, EY)
Gangnam Severance Hosp, Div Cardiol, Seoul, South Korea
0000-0003-3732-0190
Choi, Eui-Young
[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
페이지 이동: